Clinical trial
A Prospective Randomized, Double-Blind Parallel Group Trial To Assess The Efficacy And Safety Of Intravenous Dextrose 5% Solution Compare With Normal Saline (Standard Care) In Rinsing During Haemodialysis In Subjects With End Stage Renal Failure (ESRF) With Respect To Systolic Blood Pressure Control Over 3 Months Period.
NCT02590081 is registered in ClinicalTrials.gov with Penang Hospital, Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized, Double-Blind Parallel Group Trial To Assess The Efficacy And Safety Of Intravenous Dextrose 5% Solution Compare With Normal Saline (Standard Care) In Rinsing During Haemodialysis In Subjects With End Stage Renal Failure (ESRF) With Respect To Systolic Blood Pressure Control Over 3 Months Period.
- Lead sponsor
- Penang Hospital, Malaysia
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- Not reported
- Enrollment
- 434 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage kidney disease, hemodialysis